Company Filing History:
Years Active: 2007-2016
Title: The Innovative Contributions of Marc Santoro
Introduction
Marc Santoro is a notable inventor based in Yardley, PA (US), recognized for his significant contributions to the field of biotechnology. With a total of five patents to his name, he has made strides in developing fully human antibodies that target human 4-1BB, a crucial component in immunotherapy.
Latest Patents
Santoro's latest patents focus on fully human antibodies against human 4-1BB. These antibodies and their antigen-binding portions are designed to bind to human 4-1BB, facilitating its interaction with the human 4-1BB ligand. Notably, one aspect of these antibodies is that they are classified as IgG4 antibodies. Additionally, the patents include methods for treating diseases in subjects by administering a therapeutically effective amount of these antibodies.
Career Highlights
Marc Santoro is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to improve therapeutic options for patients suffering from various diseases.
Collaborations
Santoro collaborates with esteemed colleagues, including Maria N Jure-Kunkel and Laura J Hefta, who contribute to the innovative projects at Bristol-Myers Squibb Company.
Conclusion
Marc Santoro's work exemplifies the impact of innovation in biotechnology, particularly in the development of therapeutic antibodies. His contributions are vital to the advancement of medical treatments and the improvement of patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.